Herpes Simplex Virus Treatment Market Size, Share & Trends Analysis Report By Treatment (HSV-1, HSV-2), By Drug, By Vaccine, By Route Of Administration, By End-use, By Region, And Segment Forecasts, 2022 - 2030

Herpes Simplex Virus Treatment Market Size, Share & Trends Analysis Report By Treatment (HSV-1, HSV-2), By Drug, By Vaccine, By Route Of Administration, By End-use, By Region, And Segment Forecasts, 2022 - 2030

Herpes Simplex Virus Treatment Market Growth & Trends

The global herpes simplex virus treatment market size is expected to reach USD 3.75 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 10.81% from 2022 to 2030. The growth of the market is attributed to factors such as increasing prevalence of herpes infection among the population, growing awareness about the disease globally, rising geriatric and immunocompromised population, and an increasing demand to develop novel treatment options to meet the demand for herpes infection therapeutics. Moreover, public-private initiatives are further expected to fuel the growth of the market.

According to the WHO, in 2020, nearly 491.5 million people were suffering from genital herpes caused by the herpes simplex virus 2, and several billion people have herpes simplex virus 1 infection. Although the infection is typically asymptomatic, those who have it are capable of easily transmitting the virus to another person through contact. Furthermore, nearly 80 percent of the global population is a carrier of herpes. This is creating an opportunity for the growth of herpes infection treatment drugs.

Research initiatives and increasing collaborations between research organizations are facilitating the development of novel treatment alternatives against viruses, which is anticipated to boost market growth. In January 2020, a research collaboration between scientists from the EPFL in Lausanne, Switzerland, the University of Geneva (UNIGE), and the University of Manchester led to the development of novel antiviral materials, virucides, made from sugar that show promise for the treatment of herpes simplex (cold sore virus). The development of virucides from sugar has facilitated the arrival of an innovative antiviral drug, which aids treatment without being toxic to humans.

Key players operating in the market are focusing on developing novel and innovative products to meet the increasing demand for providing effective therapeutics. With the increasing demand for effective therapeutics, companies are engaged in developing novel and innovative medicines against infection. For instance, in July 2021, a Phase III study of pritelivir, a novel drug by AiCuris Anti-infective Cures AG, which is a German pharmaceutical company, was commenced, post receiving encouraging Phase II interim results from the Phase II/III trial. This leading compound is developed to treat immunocompromised patients with mucocutaneous HSV infections that are acyclovir-resistant. It was granted Breakthrough Therapy Designation by the U.S. FDA in June 2020. The regulatory support for innovative therapies is projected to improve the number of new drugs entering the market, facilitating enhanced treatment rates, and thereby accelerating market growth.

Herpes Simplex Virus Treatment Market Report Highlights

  • By treatment, the HSV-1 segment held the largest share in 2021 owing to the high prevalence of infection
  • By drug, the acyclovir segment is expected to grow at the fastest rate during the forecast period due to the effectiveness and availability of acyclovir as an oral and topical formulation
  • By vaccine, the simplirix segment is expected to grow at the fastest rate during the forecast period as it is the only vaccine available showing promising results as a vaccine candidate
  • North America dominated the global market in 2021 owing to the increasing awareness regarding STDs and the rise in healthcare expenditure
Please note The report will be delivered in 4-8 business days upon order notification.


Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Application
1.1.2 End-Use
1.1.3 Regional Scope
1.1.4 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.2 Volume Price Analysis (Model 2)
1.6.2.1 Approach 2: Volume Price Analysis
1.7 List Of Secondary Sources
1.8 List Of Primary Sources
1.9 List Of Abbreviations
1.10 Objectives
1.10.1 Objective 1
1.10.2 Objective 2
1.10.3 Objective 3
1.10.4 Objective 4
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
Chapter 3 Film dressing market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 User Perspective Analysis
3.3.1 Consumer Behavior Analysis
3.3.2 Market Influencer Analysis
3.4 List Of Key End-Users
3.5 Market Dynamics
3.5.1 Market Driver Analysis
3.5.1.1 Upsurge In Prevalence Of Chronic And Acute Wounds
3.5.1.2 Increasing Number Of Surgeries
3.5.1.3 Rising Number Of Accidents, Trauma Cases And Burn Injuries
3.5.1.4 Technological Advancements
3.5.2 Market Restraints Analysis
3.5.2.1 Stringent Manufacturing Policies
3.5.2.2 Availability Of Alternative Wound Care Products
3.6 Film Dressing: Market Analysis Tools
3.6.1 Industry Analysis - Porter’s
3.6.2 Swot Analysis, By Pest
3.7 Impact of COVID-19 on Market
Chapter 4 Film dressing market: Segment Analysis, By Application, 2018 - 2030 (USD Million)
4.1 Definition and Scope
4.2 Application Market Share Analysis, 2021 & 2030
4.3 Segment Dashboard
4.4 Global FilmDressing Market, by Application, 2018 To 2030
4.5 Market Size & Forecasts And Trend Analysis, 2018 To 2030
4.5.1 Acute Wounds
4.5.1.1 Acute Wounds Market, 2018 - 2030 (USD Million)
4.5.1.1.1 Surgical & Traumaticwounds Market, 2018 - 2030 (USD Million)
4.5.1.1.2 Burns Market, 2018 - 2030 (USD Million)
4.5.2 Chronic wounds
4.5.2.1 Chronic wounds market, 2018 - 2030 (USD Million)
4.5.2.1.1 Diabetic foot ulcers market, 2018 - 2030 (USD Million)
4.5.2.1.2 Pressure ulcers market, 2018 - 2030 (USD Million)
4.5.2.1.3 Venous leg ulcers market, 2018 - 2030 (USD Million)
4.5.2.1.4 Other chronic wounds market, 2018 - 2030 (USD Million)
Chapter 5 Film dressing market: Segment Analysis, By End-use, 2018 - 2030 (USD Million)
5.1 Definition and Scope
5.2 End-use Market Share Analysis, 2021 & 2030
5.3 Segment Dashboard
5.4 Global Film Dressing Market, by End-use, 2018 To 2030
5.5 Market Size & Forecasts And Trend Analysis, 2018 To 2030
5.5.1 Hospitals
5.5.1.1 Hospitals Market, 2018 - 2030 (USD Million)
5.5.2 Specailty Clinics
5.5.2.1 Specialty Clinics Market, 2018 - 2030 (USD Million)
5.5.3 Home Healthcare
5.5.3.1 Home Healthcare Market, 2018 - 2030 (USD Million)
5.5.4 Others
5.5.4.1 Others market, 2018 - 2030 (USD Million)
Chapter 6 Film dressing market: Regional Market Analysis,By Application, By End-use 2018 - 2030 (USD Million)
6.1 Definition & Scope
6.2 Regional Market Share Analysis, 2021 & 2030
6.3 Regional Market Dashboard
6.4 Regional Market Snapshot
6.5 Market Size, & Forecasts, Volume and Trend Analysis, 2021 to 2030
6.6 North America
6.6.1 North America Film Dressing Market, 2018 - 2030 (USD Million)
6.6.2 U.S.
6.6.2.1 U.S. Film Dressing Market, 2018 - 2030 (USD Million)
6.6.3 Canada
6.6.3.1 Canada Film Dressing Market, 2018 - 2030 (USD Million)
6.7 Europe
6.7.1 Europe Film Dressing Market, 2018 - 2030 (USD Million)
6.7.2 U.K.
6.7.2.1 U.K. Film Dressing Market, 2018 - 2030 (USD Million)
6.7.3 Germany
6.7.3.1 Germany Film Dressing Market, 2018 - 2030 (USD Million)
6.7.4 France
6.7.4.1 France Film Dressing Market, 2018 - 2030 (USD Million)
6.7.5 Italy
6.7.5.1 Italy Film Dressing Market, 2018 - 2030 (USD Million)
6.7.6 Spain
6.7.6.1 Spain Film dressing market, 2018 - 2030 (USD Million)
6.8 Asia Pacific
6.8.1 Asia Pacific Film Dressing Market, 2018 - 2030 (USD Million)
6.8.2 Japan
6.8.2.1 Japan Film Dressing Market, 2018 - 2030 (USD Million)
6.8.3 China
6.8.3.1 China (Mainland) Film Dressing Market, 2018 - 2030 (USD Million)
6.8.4 India
6.8.4.1 India Film Dressing Market, 2018 - 2030 (USD Million)
6.8.5 Australia
6.8.5.1 Australia Film Dressing Market, 2018 - 2030 (USD Million)
6.8.6 South Korea
6.8.6.1 South Korea Film dressing market, 2018 - 2030 (USD Million)
6.9 Latin America
6.9.1 Latin America Film Dressing Market, 2018 - 2030 (USD Million)
6.9.2 Brazil
6.9.2.1 Brazil Film Dressing Market, 2018 - 2030 (USD Million)
6.9.3 Mexico
6.9.3.1 Mexico Film Dressing Market, 2018 - 2030 (USD Million)
6.9.4 Argentina
6.9.4.1 Argentina Film Dressing Market, 2018 - 2030 (USD Million)
6.9.5colombia
6.9.5.1 colombia Film Dressing Market, 2018 - 2030 (USD Million)
6.10 MEA
6.10.1 MEA Film Dressing Market, 2018 - 2030 (USD Million)
6.10.2 South Africa
6.10.2.1 South Africa Film dressing market, 2018 - 2030 (USD Million)
6.10.3 Saudi Arabia
6.10.3.1 Saudi Arabia Film dressing market, 2018 - 2030 (USD Million)
6.10.4 UAE
6.10.4.1 UAE Film dressing market, 2018 - 2030 (USD Million)
Chapter 7 Film Dressing Market - Competitive Analysis
7.1 Recent Developments & Impact Analysis, By Key Market Participants
7.2 Company Categorization
7.2.1 Innovators
7.2.2 Market Leaders
7.3 Vendor Landscape
7.3.1 Key Company Market Share Analysis, 2021
7.3.2 Major Deals And Strategic Alliances
7.3.2.1 New Product Launch
7.3.2.2 Expansion
7.3.2.3 Acquistion
7.3.3 Market Entry Strategies
7.4 Company Profiles
7.4.1 CARDINAL HEALTH
7.4.1.1 Company overview
7.4.1.2 Financial performance
7.4.1.3 Product benchmarking
7.4.1.4 Strategic initiatives
7.4.2 SMITH & NEPHEW
7.4.2.1 Company overview
7.4.2.2 Financial performance
7.4.2.3 Product benchmarking
7.4.2.4 Strategic initiatives
7.4.3 3M
7.4.3.1 Company overview
7.4.3.2 Financial performance
7.4.3.3 Product benchmarking
7.4.3.4Strategic initiatives
7.4.4 PAUL HARTMANN AG
7.4.4.1 Company overview
7.4.4.2 Financial performance
7.4.4.3 Product benchmarking
7.4.4.4 Strategic initiatives
7.4.5 MCKESSON CORPORATION
7.4.5.1 Company overview
7.4.5.2 Financial performance
7.4.5.3 Product benchmarking
7.4.5.4 Strategic initiatives
7.4.6 MOLNLYCKE HEALTH CARE AB
7.4.6.1 Company overview
7.4.6.2 Financial performance
7.4.6.3 Product benchmarking
7.4.6.4 Strategic initiatives
7.4.7 MEDLINE INDUSTRIES, INC.
7.4.7.1 Company overview
7.4.7.2 Financial performance
7.4.7.3 Product benchmarking
7.4.7.4 Strategic initiatives
7.4.8 DERMARITE
7.4.8.1 Company overview
7.4.8.2 Financial performance
7.4.8.3 Product benchmarking
7.4.8.4 Strategic initiatives
7.4.9 LOHMANN & RAUSCHER
7.4.9.1 Company overview
7.4.9.2 Financial performance
7.4.9.3 Product benchmarking
7.4.9.4 Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings